4
Changes in Ownership
Renalytix plc Filed Acc 0001209191-23-041799
Options or other derivatives
- Chief Executive Officer acquired 875,017 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
McCullough James Renwick · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-07-06 | Grant or award : show line 1 in the form Employee Stock Option (right to buy) | +875,017 | 875,017 | D |
Loading xslF345X04/doc4.xml…